Catalyst Wire Dossier Catalyst Wire Dossier

Rapivab (peramivir)

peramivir · BioCryst Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Rapivab (peramivir), covering 2018-03-20 to 2018-03-20. Get the full timeline:

Most recent: Clinical Trial Update: Pharmacokinetic Assessment of Peramivir in Hospitalized Adults Undergoing Continuous Renal Replacement Therapy

See pricing